Allogene

Allogeneic CAR-T biotechs fight to escape 'nuclear winter'

As autologous CAR-T continues to improve and Big Pharma pumps big cash into next-gen approaches, is there room left at the table for allogeneic CAR-T?

Darren Incorvaia Feb 11, 2026 11:00am

Monoclonal antibody orange red background 3d rendering

Allogene reports patient death tied to mAb in CAR-T pivotal trial

Aug 1, 2025 8:30am

A series of dice with a bag on them illustrating cost cuts

Allogene lays off 28% of staff to save cash amid program delays

May 14, 2025 8:00am

Allogene’s lymphoma data show CAR-T could ‘leapfrog’ competition

Feb 14, 2025 10:35am

Allogene abandons leukemia CAR-T plans after Breyanzi approval

Nov 14, 2024 5:59am

Allogene links solid tumor CAR-T to responses, deaths in phase 1

Nov 8, 2024 4:47am